Phase II Study of Pembrolizumab in the Immunoreactive Ovarian Cancer Subtype

Project: Research project

Project Details

Description

Phase II Study of Pembrolizumab in the Immunoreactive Ovarian Cancer Subtype
StatusActive
Effective start/end date3/6/19 → 3/30/24

Funding

  • University of California Los Angeles
View all
View less